180 related articles for article (PubMed ID: 34332457)
1. A cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington.
Rice J; Hildebrand A; Spain R; Senders A; Silbermann E; Wooliscroft L; Yadav V; Bourdette D; Cameron M
Mult Scler Relat Disord; 2021 Oct; 55():103172. PubMed ID: 34332457
[TBL] [Abstract][Full Text] [Related]
2. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
Hildebrand A; Minnier J; Cameron MH
Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids and bladder symptoms in multiple sclerosis.
Kim-Fine S; Greenfield J; Chaput KH; Robert M; Metz LM
Mult Scler Relat Disord; 2021 Sep; 54():103105. PubMed ID: 34216995
[TBL] [Abstract][Full Text] [Related]
4. Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis: A 17-Year update.
Silbermann E; Senders A; Wooliscroft L; Rice J; Cameron M; Waslo C; Orban A; Chase E; Yadav V; Bourdette D; Spain RI
Mult Scler Relat Disord; 2020 Jun; 41():102041. PubMed ID: 32200340
[TBL] [Abstract][Full Text] [Related]
5. Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis.
Rice J; Hugos C; Hildebrand A; Cameron M
Mult Scler Relat Disord; 2020 Jun; 41():102009. PubMed ID: 32086163
[TBL] [Abstract][Full Text] [Related]
6. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
Weinkle L; Domen CH; Shelton I; Sillau S; Nair K; Alvarez E
Mult Scler Relat Disord; 2019 Jan; 27():383-390. PubMed ID: 30502644
[TBL] [Abstract][Full Text] [Related]
7. In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.
Pacula RL; Jacobson M; Maksabedian EJ
Addiction; 2016 Jun; 111(6):973-80. PubMed ID: 26687431
[TBL] [Abstract][Full Text] [Related]
8. Use of cannabis in patients with multiple sclerosis from Argentina.
Carnero Contentti E; López PA; Criniti J; Pettinicchi JP; Tavolini D; Mainella C; Tizio S; Tkachuk V; Silva B; Caride A; Rojas JI; Alonso R
Mult Scler Relat Disord; 2021 Jun; 51():102932. PubMed ID: 33848817
[TBL] [Abstract][Full Text] [Related]
9. Medical cannabis use in Canadians with multiple sclerosis.
Santarossa TM; So R; Smyth DP; Gustavsen DS; Tsuyuki DRT
Mult Scler Relat Disord; 2022 Mar; 59():103638. PubMed ID: 35382939
[TBL] [Abstract][Full Text] [Related]
10. Illegal cannabis use is common among Danes with multiple sclerosis.
Gustavsen S; Søndergaard HB; Andresen SR; Magyari M; Sørensen PS; Sellebjerg F; Oturai AB
Mult Scler Relat Disord; 2019 Aug; 33():5-12. PubMed ID: 31129415
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Medical Cannabis Use among Patients Diagnosed with Multiple Sclerosis.
Guarnaccia JB; Khan A; Ayettey R; Treu JA; Comerford B; Njike VY
Mult Scler Relat Disord; 2021 May; 50():102830. PubMed ID: 33636612
[TBL] [Abstract][Full Text] [Related]
12. Characterizing cannabis use in a sample of adults with multiple sclerosis and chronic pain: An observational study.
Link K; Knowles LM; Alschuler KN; Ehde DM
Mult Scler Relat Disord; 2023 Jul; 75():104742. PubMed ID: 37156034
[TBL] [Abstract][Full Text] [Related]
13. Use of natural medicine and dietary supplements concomitant with conventional medicine among people with Multiple Sclerosis.
Bergien SO; Petersen CM; Lynning M; Kristiansen M; Skovgaard L
Mult Scler Relat Disord; 2020 Sep; 44():102197. PubMed ID: 32531752
[TBL] [Abstract][Full Text] [Related]
14. Frequency and characteristics of falls in people living with and without multiple sclerosis during the COVID-19 pandemic: A cross-sectional online survey.
Zanotto T; Frechette ML; Koziel SR; Hsieh KL; Sosnoff JJ
Mult Scler Relat Disord; 2021 Sep; 54():103111. PubMed ID: 34303279
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneities in administration methods among cannabis users by use purpose and state legalization status: findings from a nationally representative survey in the United States, 2020.
Shi Y
Addiction; 2021 Jul; 116(7):1782-1793. PubMed ID: 33217090
[TBL] [Abstract][Full Text] [Related]
16. Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.
Iaffaldano P; Lucisano G; Manni A; Paolicelli D; Patti F; Capobianco M; Brescia Morra V; Sola P; Pesci I; Lus G; De Luca G; Lugaresi A; Cavalla P; Montepietra S; Maniscalco GT; Granella F; Ragonese P; Vianello M; Brambilla L; Totaro R; Toscano S; Malucchi S; Petracca M; Moiola L; Ferraro D; Lepore V; Mosconi P; Ponzio M; Tedeschi G; Comi G; Battaglia MA; Filippi M; Amato MP; Trojano M;
Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35046084
[TBL] [Abstract][Full Text] [Related]
17. Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths.
Shinto L; Calabrese C; Morris C; Sinsheimer S; Bourdette D
J Altern Complement Med; 2004 Oct; 10(5):891-7. PubMed ID: 15650479
[TBL] [Abstract][Full Text] [Related]
18. Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study.
Vogel AC; Schmidt H; Loud S; McBurney R; Mateen FJ
Mult Scler Relat Disord; 2020 Nov; 46():102512. PubMed ID: 32977074
[TBL] [Abstract][Full Text] [Related]
19. Smoking, vaping, eating: Is legalization impacting the way people use cannabis?
Borodovsky JT; Crosier BS; Lee DC; Sargent JD; Budney AJ
Int J Drug Policy; 2016 Oct; 36():141-7. PubMed ID: 26992484
[TBL] [Abstract][Full Text] [Related]
20. The importance of the patient's perspective in decision-making in multiple sclerosis: Results of the OwnMS patient perspectives study.
Florio-Smith J; Ayer M; Colhoun S; Daykin N; Hamill B; Liu X; Rogers E; Thomson A; Balzan RP
Mult Scler Relat Disord; 2023 Jul; 75():104757. PubMed ID: 37210990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
